{"disease":{"id":"retinal-edema","name":"retinal edema"},"drugs":{"marketed":[{"drug_id":"aflibercept","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vegf Trap","generic_name":"AFLIBERCEPT","company_name":"Regeneron","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"Vascular Endothelial Growth Factor Inhibitor","quality_score":55,"revenue":"9800","mechanism":""},{"drug_id":"aflibercept","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vegf Trap","generic_name":"AFLIBERCEPT","company_name":"Regeneron","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"Vascular Endothelial Growth Factor Inhibitor","quality_score":55,"revenue":"9800","mechanism":""},{"drug_id":"eylea","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Eylea","company_name":"Texas Retina Associates","drug_phase":"marketed","molecular_target":"Placenta growth factor, Vascular endothelial growth factor A, Vascular endothelial growth factor B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"eylea","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Eylea","company_name":"Texas Retina Associates","drug_phase":"marketed","molecular_target":"Placenta growth factor, Vascular endothelial growth factor A, Vascular endothelial growth factor B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"lucentis","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lucentis","company_name":"Santen Inc.","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lucentis","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lucentis","company_name":"Santen Inc.","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ranibizumab-nuna","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BYOOVIZ","generic_name":"RANIBIZUMAB-NUNA","company_name":"SAMSUNG BIOEPIS CO LTD","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"ranibizumab-nuna","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BYOOVIZ","generic_name":"RANIBIZUMAB-NUNA","company_name":"SAMSUNG BIOEPIS CO LTD","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03753893","title":"Ocular Manifestations in Rheumatic Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT06213896","title":"Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images","phase":"","overall_status":"COMPLETED","enrollment_count":1528,"lead_sponsor_name":"Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi","has_results":false},{"nct_id":"NCT05130385","title":"High Resolution Optical Coherence Tomography","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT03211741","title":"Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT07514559","title":"Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":393,"lead_sponsor_name":"Hospital Hietzing","has_results":false},{"nct_id":"NCT01918371","title":"A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema","phase":"","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01427751","title":"Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03108352","title":"Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":255,"lead_sponsor_name":"Chengdu Kanghong Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT04455399","title":"Time Efficiency Comparison of Two IntraVitreal Injection Techniques","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Peregrine Eye and Laser Institute","has_results":false},{"nct_id":"NCT04516278","title":"A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Outlook Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07002372","title":"Effect of Video Viewing on Intravitreal Injection Experience","phase":"NA","overall_status":"RECRUITING","enrollment_count":182,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03056079","title":"Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":168,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT07019896","title":"Minimal Vitrectomy Surgery for Epiretinal Membrane","phase":"NA","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT01573572","title":"Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT05832996","title":"Cool vs Room-temperature Artificial Tears","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"University of Iowa","has_results":true},{"nct_id":"NCT03790852","title":"Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":121,"lead_sponsor_name":"Kodiak Sciences Inc","has_results":false},{"nct_id":"NCT04444492","title":"Combination of Ranibizumab and Targeted Laser Photocoagulation","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT03709745","title":"Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"St. Erik Eye Hospital","has_results":false},{"nct_id":"NCT04690608","title":"Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema, CRVO, Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema Following Pars Plana Vitrectomy","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT02585401","title":"Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada","phase":"","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04501367","title":"Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Kovach Eye Institute","has_results":false},{"nct_id":"NCT04140448","title":"Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Renmin Hospital of Wuhan University","has_results":false},{"nct_id":"NCT04576689","title":"Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Ripple Therapeutics Pty Ltd","has_results":false},{"nct_id":"NCT04290195","title":"Use of Ziv Aflibercept in Different Retinal Diseases","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Amin El Sayed Nawar","has_results":false},{"nct_id":"NCT06011798","title":"Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Unity Biotechnology, Inc.","has_results":true},{"nct_id":"NCT03590444","title":"Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Hospital Hietzing","has_results":false},{"nct_id":"NCT01847638","title":"Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Melissa Toyos","has_results":true},{"nct_id":"NCT03405376","title":"Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":49,"lead_sponsor_name":"Yeungnam University College of Medicine","has_results":false},{"nct_id":"NCT03651011","title":"Navigated Laser In Branch Retinal Vein Occlusion Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Odense University Hospital","has_results":false},{"nct_id":"NCT05282420","title":"Ranibizumab Versus Aflibercept for CRVO in Young Patients.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"South Valley University","has_results":false},{"nct_id":"NCT04142164","title":"Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Prim. Prof. Dr. Oliver Findl, MBA","has_results":false},{"nct_id":"NCT03892434","title":"Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Yeungnam University College of Medicine","has_results":false},{"nct_id":"NCT03321253","title":"Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification","phase":"NA","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Afyon Kocatepe University Hospital","has_results":true},{"nct_id":"NCT07501052","title":"Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":33,"lead_sponsor_name":"Sam Chun Dang Pharm. Co. Ltd.","has_results":false},{"nct_id":"NCT02503540","title":"Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Justis Ehlers","has_results":true},{"nct_id":"NCT03093701","title":"TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Taiwan Liposome Company","has_results":true},{"nct_id":"NCT06708624","title":"Ocular Safety and Usability Study for FYB201 PFS","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Formycon AG","has_results":false},{"nct_id":"NCT04812977","title":"Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Hayatabad Medical Complex","has_results":true},{"nct_id":"NCT06708637","title":"Ocular Safety and Usability Study for FYB203 PFS","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Formycon AG","has_results":false},{"nct_id":"NCT03404323","title":"\"Cataract Surgery in Eyes With Epiretinal Membrane\"","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"St John of God Hospital, Vienna","has_results":false},{"nct_id":"NCT04300881","title":"Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Wagner Macula & Retina Center","has_results":false}],"total":41},"guidelines":[],"source":"Drug Landscape verified database"}